Alejandro Navarro

机构：Breast Cancer Research Foundation, MedSIR (Spain), Vall d'Hebron Institut de Recerca, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Biomedical Research Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Vall d'Hebron Institute of Oncology, Universitat de Barcelona · ORCID：0000-0001-5903-270X

发表论文 181 篇 · 总被引 6147 次 · h-index 31

代表论文

• Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (2024 · New England Journal of Medicine · 被引 307)
• ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC). (2024 · Journal of Clinical Oncology · 被引 48)
• RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 38)
• OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01 (2024 · Journal of Thoracic Oncology · 被引 32)
• Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study (2025 · Journal of Thoracic Oncology · 被引 13)
• A murine experimental model of the pulmonary thrombotic effect induced by the venom of the snake Bothrops lanceolatus (2024 · PLoS neglected tropical diseases · 被引 6)